The National Federation of the Blind (NFB), the oldest and largest nationwide organization of blind Americans, and OrCam Technologies, the world’s most advanced wearable AI-driven artificial vision innovator, jointly announced a cooperative agreement at the NFB’s annual National Convention that will help empower blind and low vision Americans to achieve increased independence.
Diabetic retinopathy affects blood vessels in the light-sensitive tissue called the retina that lines the back of the eye. It is the most common cause of vision loss among people with diabetes and the leading cause of vision impairment and blindness among working-age adults.
Wireless, lightweight and compacted into the size of a finger, the pioneering technology of the AI-driven OrCam MyEye 2 artificial vision device discreetly reads printed and digital text aloud – from any surface – in real time. The OrCam speaks the text aloud making newspapers, books, computer and smartphone screens, restaurant menus, labels on supermarket products and street signs become immediately accessible. The OrCam can also identify various products, US currency, credit cards, and even faces.
OrCam comes in two versions: OrCam MyEye, which is priced at $3,500, andOrCam MyReader, which costs $2,500. Let’s take these configurations one by one, describing what they can and can’t do.
Catherine Lawerence shares her experience of living with type 1 diabetes for 50 years and being diagnosed with diabetic retinopathy on July’s Diabetes Late Nite podcast with musical inspiration from P!nk.
Additional podcast guests include Beyond Type 2’s T’ara Smith, Catherine Lawrence , Dr. Sara (Mandy) Reece PHARMD, CDE, BC-ADM, BCACP, FAADE, Poet Lorraine Brooks, Glamazon Beauty owner Kim Baker, and the Charlie’s Angels of Outreach. Hosted by the happiest health care “MC,” Max “Mr. Divabetic” Szadek.
